Slaughtered swine as convergence hotspots for antimicrobial-resistant and disinfectant-tolerant Escherichia coli originating from humans and farm animals
Year: 2026
Type: article
Abstract: This study presents regional One Health surveillance of Escherichia coli across a farm–slaughterhouse–human continuum in rural China, clarifying where hazardous strains co-carrying clinically important antimicrobial-resistance genes and disinfectant-tolerance determinants are enriched and disseminated. We analyzed 300 E. coli isolates, comprising 200 non-clinical and 100 clinical isolates. The non-clinical isolates were recovered from 526 samples collected across poultry and swine farms, a swine slaughterhouse, community carriers, and environmental matrices, while the clinical isolates were obtained from a local hospital. Populations were strongly source-structured. Clinical isolates were dominated by high-risk lineages ST1193 and ST131, while animal isolates were enriched for ST155. Third-generation cephalosporin resistance was near-universal in patients and slaughtered swine (97.7–100%) but low in farmed swine (8.3%), indicating pronounced amplification at the slaughterhouse interface. Accessory-genome profiling showed source-specific hazard signatures. Animal isolates carried the highest burden of resistance and stress response genes, whereas clinical isolates were enriched in virulence determinants ( iuc , ybt , iss ) and highly mobile, high-priority resistance features, yielding comparable resistance health-risk indices. Notably, slaughtered swine isolates co-carried bla CTX-M-14 , floR , and qac , linking 3GCR, farm-associated phenicol resistance, and disinfectant tolerance in a single hotspot. A gene-based XGBoost source-attribution model identified slaughterhouses as critical convergence nodes for high-risk E. coli and mobile resistance elements.
Source: Journal of Hazardous Materials
Authors: Chendi Zhu, Ruishan Liu, Xin Liu, Hao Xu, Olivia Chan, Yuzhou Chen, Yongzhang Zhu, Beiwen Zheng, Hein Min Tun
Language: English
Subfield: Molecular Medicine
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,340
Funders: Wellcome Trust, Department of Health and Social Care, National University of Singapore, National Natural Science Foundation of China, Research Grants Council, University Grants Committee, University of Hong Kong, Zhejiang University, Guangxi Medical University, National University's Basic Research Foundation of China, Key Technologies Research and Development Program, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities
OpenAlex ID: W7148585262
